Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1995
03/23/1995CA2171955A1 Pharmaceutical composition comprising monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
03/23/1995CA2171868A1 Method for dosing therapeutic compounds
03/23/1995CA2171608A1 Novel salts of amino glycosides
03/23/1995CA2171318A1 Adeno-associated viral (aav) liposomes and methods related thereto
03/23/1995CA2170638A1 Improvements in or relating to haemoglobin
03/23/1995CA2170405A1 Activin receptors-like kinase (alk), belonging to the tgf receptor family and/or to the bmp receptor family
03/23/1995CA2170030A1 Pharmaceutical compositions containing ecotin and homologs thereof
03/23/1995CA2169938A1 Grb3-3 gene; variants and uses thereof
03/23/1995CA2168870A1 Skin care method and composition
03/23/1995CA2168869A1 Skin care composition comprising thiol proteases from the stratum corneum
03/23/1995CA2168332A1 Activated factor viii as a therapeutic agent and method of treating factor viii deficiency
03/23/1995CA2166531A1 Skin care method and composition
03/23/1995CA2149323A1 Therapeutic agent for treating wounds
03/22/1995EP0644262A2 Gene coding for a protein regulating aureobasidin sensitivity
03/22/1995EP0644203A1 IL-1alpha derivatives and medicament for treating thrombocytopenia
03/22/1995EP0644199A1 Cyclic antimicrobial peptides and preparation thereof
03/22/1995EP0644198A1 Alpha-heteroaryloxymethyl ketones as interleukin-1beta converting enzyme inhibitors
03/22/1995EP0644197A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
03/22/1995EP0644181A1 Amino acid derivative and use thereof
03/22/1995EP0643974A1 Vaccine against lyme disease
03/22/1995EP0643973A1 Use of human interferon-beta for the preparation of pharmaceutical compositions for treating Chronic Myeloid Leukemia
03/22/1995EP0643972A2 Use of recombinant colony stimulating factor-1 for the preparation of a medicament for cytomegalovirus infections and leukopenia
03/22/1995EP0643971A2 Antifungal compositions consisting of an antifungal agent, e.g. antibiotic R-106I, and a fungal MDR inhibitor
03/22/1995EP0643780A1 Multiple solvent cleaning system.
03/22/1995EP0643770A1 Helicobacter pylori proteins useful for vaccines and diagnostics
03/22/1995EP0643769A1 RECOMBINANT TIMOTHY GRASS POLLEN ALLERGEN $i(Phl p) II
03/22/1995EP0643767A1 Osteogenic peptides
03/22/1995EP0643728A1 Icam-related protein
03/22/1995EP0643726A1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES
03/22/1995EP0643725A1 Single chain peptide compounds having hemoregulatory activity
03/22/1995EP0643719A1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
03/22/1995EP0643608A1 Protein purification
03/22/1995EP0643586A1 Compositions useful in diagnosis and prophylaxis of lyme disease
03/22/1995EP0643585A1 A method for using lipoprotein associated coagulation inhibitor to treat sepsis
03/22/1995EP0643583A1 Intraoperative, intravascular and endoscopic tumor and lesion detection and therapy
03/22/1995EP0643582A1 Method for producing a supernatant of activated thrombocytes
03/22/1995EP0643580A1 Combinations of ace inhibitors and diuretics
03/22/1995EP0643559A1 Diphtheria toxin receptor-binding region
03/22/1995EP0527803B1 Composition for macrophage activation
03/22/1995EP0502054B1 An aerosol preparation of glutathione and a method for augmenting glutathione level in lungs
03/22/1995EP0495877B1 Methods and compositions for healing bone
03/22/1995EP0440763B1 t-PA MUTANT GK1L
03/22/1995EP0428636B1 Use of interleukin 2 to treat endotoxinemia
03/22/1995EP0301087B1 Peptide
03/22/1995EP0299050B1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid
03/22/1995EP0228452B1 Protein purification
03/22/1995CN1100428A Improved meningococcal polysaccharide conjugate vaccine
03/22/1995CN1100426A Lysosomal enzyme-cleavable antitumor drug conjugates
03/22/1995CN1100413A Urethanes and ureas that induce cytokine production
03/22/1995CN1100327A Use of VIP, analogues and fragments thereof for the treatment of neurodegenerative diseases
03/22/1995CN1100301A Drug for neuroprotection
03/22/1995CN1100272A Composition and process for enhancing the pre-adult growth and feed conversion efficiency of a porcine animal
03/21/1995US5399741 DNA gyrase inhibitors, process for their manufacture and pharmaceutical preparations containing same
03/21/1995US5399671 Specifically crosslinked hemoglobin with free functionality
03/21/1995US5399670 Arginine, histidine, human serum albumin
03/21/1995US5399667 Thrombospondin receptor binding peptides
03/21/1995US5399570 Aspartic acid derivatives, and their use for inhibiting platelete aggregation
03/21/1995US5399560 1,2,4-triazine products resulting from the inhibition of advanced glycosylation
03/21/1995US5399552 Antibiotic peptides bearing aminoalkylthioether moieties
03/21/1995US5399551 Enhancer for the antianemia effect of erythropoietin and method of augmenting the antianemia effect of erythropoietin
03/21/1995US5399550 Physiologically active substance derived or malt and process for the production thereof
03/21/1995US5399485 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis caused by Rochalimaea henselae
03/21/1995US5399347 Method of treating rheumatoid arthritis with type II collagen
03/21/1995US5399346 Gene therapy
03/21/1995US5399345 His at position 52 is substituted with Ser, Arg, or Glu
03/21/1995US5399341 Use of cytokin-containing aerosols and the cytokin-containing aerosols
03/21/1995US5399331 Method for protein-liposome coupling
03/21/1995CA2132396A1 Physiologically active substance-prolonged releasing-type pharmaceuticalpreparation
03/16/1995WO1995007453A1 A method for purifying a membrane-associated protein
03/16/1995WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
03/16/1995WO1995007348A1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
03/16/1995WO1995007301A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders
03/16/1995WO1995007297A1 Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
03/16/1995WO1995007296A1 Method and means for producing plasmaproteinase inhibitor-binding proteins
03/16/1995WO1995007295A1 Analogs of hirudin
03/16/1995WO1995007294A1 Pseudo- and non-peptide bradykinin receptor antagonists
03/16/1995WO1995007293A1 Phospholipase c inhibiting peptide
03/16/1995WO1995007292A1 Antibiotics 10381v, w, x, y, z1, z2, pre-b and t
03/16/1995WO1995007291A1 Kininogen inhibitors
03/16/1995WO1995007269A1 Polar-substituted hydrocarbons
03/16/1995WO1995007261A1 Polyamidic acid derivatives with antigastrin activity, a method for their preparation, and their pharmaceutical use
03/16/1995WO1995007257A1 Difluoro statone antiviral analogs
03/16/1995WO1995007108A2 Formulations for delivery of osteogenic proteins
03/16/1995WO1995007105A1 Haplotype-matched cytokine-secreting cells and methods of using to stimulate an immune response
03/16/1995WO1995007102A1 A method of promoting cellular function
03/16/1995WO1995007098A1 Methods for regulating gastrointestinal motility
03/16/1995WO1995007097A1 Inhibition of heparin-binding
03/16/1995WO1995007096A1 Treatment of autoimmune disease
03/16/1995WO1995007095A1 Injectable compositions for soft tissue augmentation
03/16/1995WO1995007094A1 Compositions and methods for inhibiting hepatocyte invasion by malarial sporozoites
03/16/1995WO1995007093A1 Method for design of substances that enhance memory and improve the qualilty of life
03/16/1995WO1995007092A1 Blood-brain barrier transporters of neurological agents
03/16/1995WO1995007089A1 Immunomodulating compositions from bile
03/16/1995WO1995007088A1 RECOMBINANT α-GALACTOSIDASE ENZYME AND cDNA ENCODING SAID ENZYME
03/16/1995WO1995007087A1 Sulfamethoxazole-specific immunosuppressive agents
03/16/1995WO1995007086A1 Nucleosides with anti-hepatitis b virus activity
03/16/1995WO1995007073A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
03/16/1995WO1995007020A1 EXPRESSION OF THE DEVELOPMENTAL I ANTIGEN BY A CLONED HUMAN cDNA ENCODING A BETA-1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE
03/16/1995WO1995003415A3 Epstein-barr virus dna sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
03/16/1995WO1995003405A3 Enzymatic method for modification of recombinant polypeptides
1 ... 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 2866 2867 2868 2869 2870 2871 2872 2873 2874 2875 ... 3163